Fanconi anemia (FA) is a rare inherited disorder characterized by progressive bone marrow failure, congenital abnormalities, and heightened cancer susceptibility. This syndrome results from mutations in any of at least 16 genes that encode proteins forming the FA pathway, a critical cellular response system activated by DNA damage and replication stress. While the primary role of the FA pathway has long been recognized in DNA repair and genome stability, emerging evidence suggests additional functions in transcriptional regulation. A pivotal study reveals that the Fanconi C protein (FANCC), in concert with the transcriptional corepressor CtBP1, forms a complex with -catenin—a key mediator of Wnt signaling—and regulates the expression of Dickkopf-1 (DKK1), a potent inhibitor of Wnt signaling. Activation of -catenin through inhibition of glycogen synthase kinase 3 (GSK3) triggers nuclear translocation of both FANCC and -catenin, facilitating their interaction and subsequent modulation of target gene expression. Notably, this process requires an intact FA pathway, as cells deficient in FANCA, FANCD2, or harboring disease-causing FANCC mutations fail to accumulate FANCC in the nucleus or activate downstream FA pathway markers such as monoubiquitinated FANCD2.
Further investigation demonstrates that the FANCC–CtBP1 complex acts as a transcriptional repressor of DKK1. Overexpression of wild-type FANCC leads to dose-dependent suppression of DKK1 promoter activity, an effect significantly enhanced when co-expressed with CtBP1.Arginylaspartic acid medchemexpress However, this repressive function is lost when FANCC carries the L554P mutation, a known pathogenic variant associated with FA.Bedaquinoline impurity 18 Protocol Consistent with these findings, patient-derived FANCC-deficient cells exhibit markedly elevated DKK1 expression compared to genetically corrected counterparts.PMID:34304656 Similarly, depletion of FANCD2 or CtBP1 results in increased DKK1 reporter activity, indicating that multiple components of the FA pathway are essential for maintaining DKK1 repression. These observations suggest a dual regulatory mechanism: while the FA pathway promotes activation of Wnt-responsive genes via FANCD2, it simultaneously suppresses DKK1 expression through FANCC–CtBP1, thereby fine-tuning Wnt signaling homeostasis.
This dual functionality provides insight into the pathophysiology of FA. Dysregulation of DKK1 due to defective FA signaling may contribute to hematopoietic stem cell (HSC) exhaustion and impaired self-renewal—hallmarks of FA-associated bone marrow failure. Elevated DKK1 levels have been linked to accelerated HSC cycling and reduced regenerative capacity, phenomena observed in FA patients. Moreover, chronic overexpression of DKK1 is implicated in several malignancies, including multiple myeloma and head and neck cancers, which are more prevalent in FA individuals. Thus, the FA pathway emerges not only as a guardian of genomic integrity but also as a crucial regulator of developmental and oncogenic signaling networks.
These findings redefine the functional scope of the FA pathway beyond DNA repair. By integrating transcriptional control with canonical Wnt signaling, the FA pathway ensures balanced cellular responses to stress and maintains tissue homeostasis. Targeting DKK1 or modulating the FANCC–CtBP1 axis may offer novel therapeutic strategies for mitigating bone marrow failure and preventing leukemic transformation in FA patients. Future research should explore whether pharmacological restoration of DKK1 regulation can rescue HSC dysfunction in FA models, potentially leading to targeted interventions aimed at preserving hematopoietic function in this devastating disease.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com